Conclusion

Hearing Sense Recovery

Help For Hearing Loss Sufferers

Get Instant Access

With continued advances in our understanding of the molecular biology of hearing and deafness, the clinical management of deafness will become more sophisticated. Molecular genetic testing will be used to unequivocally diagnose many different forms of inherited deafness, providing prognostic information for patients and their families. Novel habilitation options will be developed that will be applicable to select persons with specific types of genetic deafness. At the forefront of these advances will be the ability to offer precise genetic testing that is rapid, robust, and cost-effective.

Acknowledgments

This work was supported in part by grants DC02842 and DC03544 (RJHS).

References

1. Smith RJH, Green GE, Van Camp G. Hereditary hearing loss and deafness [GeneClinics Web site]. 2003. Available at: http://www. geneclinics.org/.

2. Green GE, Scott DA, McDonald JM, et al. Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA. 1999;281:2211-2216.

3. Van Camp G,Smith RJH. [Hereditary Hearing Loss home page].2003. Available at: http://webhost.ua.ac.be/hhh/.

4. Guilford P, Ben Arab S, Blanchard S, et al. A non-syndromic form of neurosensory, recessive deafness maps to the pericentromeric region of chromosome 13q. Nat Genet. 1994;6:24-28.

5. Kelsell DP, Dunlop J, Stevens HP, et al. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature. 1997;387: 80-83.

6. Bruzzone R, White TW, Paul DL. Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem. 1996;238:1-27.

7. Zelante L, Gasparini P, Estivill X, et al. Connexin 26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum Mol Genet. 1997;6:1605-1609.

8. Denoyelle F, Weil D, Maw MA, et al. Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum Mol Genet. 1997;6:2173-2177.

9. Estivill X, Fortina P, Surrey S, et al. Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet. 1998;351:394-398.

10. Scott DA, Kraft ML, Carmi R, et al. Identification of mutations in the connexin 26 gene that cause autosomal recessive nonsyndromic hearing loss. Hum Mutat. 1998;11:387-394.

11. Cohn ES, Kelley PM, Fowler TW, et al. Clinical studies of families with hearing loss attributable to mutations in the connexin 26 gene. Pediatrics. 1999:103;546-550.

12. Kikuchi T, Adams JC, Paul DL, et al. Gap junction systems in the rat vestibular labyrinth: immunohistochemical and ultrastructural analysis. Acta Otolaryngol. 1994;114:520-528.

13. Kikuchi T,Kimura RS, Paul DL,et al. Gap junctions in the rat cochlea: immunohistochemical and ultrastructural analysis. Anat Embryol (Berl). 1995;191:101-118.

14. Tekin M, Arnos KS, Pandya A. Advances in hereditary deafness. Lancet. 2001;358:1082-1090.

15. Estivill X, Gasparini P [Connexin-deafness homepage]. 2003. Available at: http://davinci.crg.es/deafness/.

16. Van Laer L, Coucke P, Mueller RF, et al. A common founder for the 35delG connexin 26 (GJB2) gene mutation in non-syndromic hearing impairment. J Med Genet. 2001;38:515-518.

17. Kelley PM, Harris DJ, Comer BC, et al. Novel mutations in the con-nexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss. Am J Hum Genet. 1998;62:792-799.

18. Morell RJ, Kim HJ, Hood LJ, et al. Mutations in the connexin 26 gene (GJB2) among Ashkenzi Jews with nonsyndromic recessive deafness. N Eng J Med. 1998;339:1500-1505.

19. Kudo T, Ikeda K, Kure S, et al. Novel mutations in the connexin 26 gene (GJB2) responsible for childhood deafness in the Japanese population. Am J Med Genet. 2000;90:141-145.

20. Denoyelle F, Marlin S, Weil D, et al. Clinical features of the prevalent form of childhood deafness, DFNB1,due to a connexin-26 gene defect: implications for genetic counseling. Lancet. 1999;353:1298-1303.

21. Green GE, Mueller RF, Cohn ES, Avraham KB, Kanaan M, Smith RJH. Audiological manifestations and features of Connexin 26 deafness. Audiolog Med 2003;1:5-11.

22. Kenna MA, Wu BL, Cotanche DA, et al. Connexin 26 studies in patients with sensorineural hearing loss. Arch Otolaryngol Head Neck Surg. 2001;127:1037-1042.

23. Hohl D. Towards a better classification of erythrokeratodermias. Br J Dermatol. 2000;143:1133-1137.

24. Maestrini E, Korge BP, Ocana-Sierra J, et al. A missense mutation in connexin26, D66H, causes mutilating keratoderma with sen-sorineural deafness (Vohwinkel's syndrome) in three unrelated families. Hum Mol Genet. 1999;8:1237-1243.

25. Fukushima K, Sugata K, Kasai N, et al. Better speech performance in cochlear implant patients with GJB2-related deafness. Int J Pediatr Otorhinolaryngol. 2002;62:151-157.

26. Green GE, Scott DA, McDonald JM, et al. Performance of cochlear implant recipients with GJB2-related deafness. Am J Med Genet. 2002;109:167-170.

27. Smith RJ. Mutation screening for deafness: more than simply another diagnostic test. Arch Otolaryngol Head Neck Surg. 2001;127: 941-942.

28. Mueller RF, Nehammer A, Middleton A, et al. Congenital non-syndromal sensorineural hearing impairment due to connexin 26 gene mutations—molecular and audiological findings. Int J Pediatr Otorhinolaryngol. 1999;50:3-13.

29. Sobe T,Vreugde S, Shahin H, et al. The prevalence and expression of inherited connexin 26 mutations associated with nonsyndromic hearing loss in the Israeli population. Hum Genet. 2000;106:50-57.

30. Ellis LA, Taylor CF, Taylor GR. A comparison of fluorescent SSCP and denaturing HPLC for high throughput mutations screening. Hum Mutat. 2000;15:556-564.

31. Liu WG, Smith DI, Rechtzigel KJ, et al. Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. Nucleic Acids Res. 1998;26:1396-1400.

32. O'Donovan MC, Oefner PJ, Roberts SC, et al. Blind analysis of denaturing high-performance liquid chromatography as tool for mutation detection. Genomics. 1998;52:44-49.

33. Taliani MR, Roberts SC, Dukek BA, et al. Sensitivity and specificity of denaturing high-pressure liquid chromatography for unknown protein C gene mutations. Genet Test. 2001;5:39-44.

34. Everett LA, Glaser B, Beck JC, et al. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet. 1997;17:411-422.

35. Phelps PD, Coffey RA, Trembath RC, et al. Radiological malformations of the ear in Pendred syndrome. Clin Radiol. 1998;53:268-273.

36. Reardon W, Coffey R, Chowdhury T, et al. Prevalence, age of onset, and natural history of thyroid disease in Pendred syndrome. J Med Genet. 1999;36:595-598.

37. Morgans ME, Trotter WR. Association of congenital deafness with goitre: the nature of the thyroid defect. Lancet. 1958;1:607-609.

38. Li XC, Everett LA, Lalwani AK, et al. A mutation in PDS causes nonsyndromic recessive deafness. Nat Genet. 1998;18:215-217.

39. Scott DA, Wang R, Kreman TM, et al. Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and nonsyndromic hearing loss. Hum Mol Genet. 2000;9:1709-1715.

40. Johnsen T, Sorensen MS, Feldt-Rasmussen U, et al. The variable intrafamiliar expressivity in Pendred's syndrome. Clin Otolaryngol. 1989;14:395-399.

41. Yong AML, Goh SS, Zhao Y, et al. Two Chinese families with Pendred's syndrome—radiological imaging of the ear and molecular analysis of the pendrin gene. J Clin Endocrin Metab. 2001;86:3907-3911.

42. Campbell C, Cucci RA, Green GE, et al. Pendred syndrome, DFNB4 and PDS—Identification of eight novel mutations and phenotype-genotype correlations. Hum Mut. 2001;17:403-411.

43. Chang E,Kolln K,Smith RJH. [Pendred syndrome/BOR homepage]. 2003.Available at: http://www.medicine.uiowa.edu/pendredandbor/.

44. Masmoudi S, Charfedine I, Hmani M, et al. Pendred syndrome: phe-notypic variability in two families carrying the same PDS missense mutation. Am J Med Genet. 2000;90:38-44.

45. Prasad S, Kölln KA, Cucci RA, Trembath RC,Van Camp G, Smith RJH. Pendred syndrome and DFNB4—Mutation screening of SLC26A4 by denaturing high-performance liquid chromatography and the identification of seven novel mutations.Am J Med Genet 124A:1-9,2004.

46. Coyle B, Reardon W, Herbrick J, et al. Molecular analysis of the PDS gene in Pendred syndrome (sensorineural hearing loss and goitre). Hum Mol Genet. 1998;7:1105-1112.

47. Bespalova IN, Van Camp G, Bom SJ, et al. Mutations in the Wolfram syndrome 1 gene (WFS1) area a common cause of low frequency sensorineural hearing loss. Hum Mol Genet. 2001;10:2501-2508.

48. Young TL, Ives E, Lynch E, et al. Non-syndromic progressive hearing loss DFNA38 is caused by heterozygous missense mutation in the Wolfram syndrome gene WFS1. Hum Mol Genet. 2001;10:2509-2514.

49. Kunst HPM, Marres HAM, Huygen PLM, et al. Autosomal dominant non-syndromal low-frequency sensorineural hearing impairment linked to chromosome 4p16 (DFNA14): statistical analysis of hearing threshold in relation to age and evaluation of vestibulo-ocular functions. Audiology. 1999;38:165-173.

50. Brodwolf S, Böddeker IR, Ziegler A, et al. Further evidence for linkage of low-mid frequency hearing impairment to the candidate region on chromosome 4p16.3. Clin Genet. 2001;60:155-160.

51. Huygen PLM, Bom SJ, Van Camp G, et al. The clinical presentation of the DFNA loci where causative genes have not yet been cloned: DFNA4, DFNA6/14, DFNA7, DFNA16, DFNA20 and DFNA21. In: Cremers CWRJ, Smith RJH, eds. Advances in Otorhinolaryngology. Basel: Karger; 2002;98-106.

52. Bom SJH, Van Camp G, Cryns K, et al. Autosomal dominant low-frequency hearing impairment (DFNA6/14): a clinical and genetic family study. Otol Neurotol. 2002:23:876-884.

53. Lynch ED, Lee MK, Morrow JE, et al. Nonsyndromic deafness DFNA1 associated with mutation of a human homolog of the Drosophila gene diaphanous. Science. 1997;278:1223-1224.

54. Inoue H, Tanizawa Y, Wasson J, et al. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet. 1998;20:143-148.

55. Strom TM, Hörtnagel K, Hofmann S, et al. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum Mol Genet. 1998;7:2021-2028.

56. Cremers CWRJ, Wijdeveld PG, Pinckers AJ. Juvenile diabetes melli-tus, optic atrophy, hearing loss, diabetes insipidus, atonia of the urinary tract and bladder, and other abnormalities (Wolfram syndrome): a review of 88 cases from the literature with personal observations on 3 new patients. Acta Paediatr Scand Suppl. 1977;264:1-16.

57. Higashi K. Otologic findings of DIDMOAD syndrome. Am J Otol. 1991;12:57-60.

58. Cryns K, Pfister M, Pennings RJE, et al. Mutations in the WFS1 gene that cause low frequency sensorineural hearing loss are small non-inactivating mutations. Hum Genet. 2002;110:389-394.

59. Prasad S, Kölln KA, Cucci RA, Trembath RC,Van Camp G, Smith RJH. Pendred syndrome and DFNB4-Mutation screening of SLC26A4 by denaturing high-performance liquid chromatography and the identification of seven novel mutations. Am J Med Genet. 2004;124A:1-9.

60. Takeda K, Inoue H, Tanizawa Y, et al. WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. Hum Mol Genet. 2001;10:477-484.

61. Sivakumaran TA, Lesperance MM. WFS1 Gene Mutation and Polymorphism Database [database online]. 2003. Available at: http:// www.khri.med.umich.edu/research/lesperance_lab/lfsnhl.shtml.

62. Awata T, Inoue K, Kurihara S, et al. Missense variations of the gene responsible for Wolfram syndrome (WFS1/wolframin) in Japanese: possible contribution of the Arg456His mutation to type 1 diabetes as a nonautoimmune genetic basis. Biochem Biophys Res Commun. 2000;268:612-616.

63. Minton JAL, Hattersley AT, Owen K, et al. Association studies of genetic variation in the WFS1 gene and type 2 diabetes in U.K. populations. Diabetes. 2002;51:1287-1290.

64. Domenech E, Gomez-Zaera M, Nunes V. WFS1 mutations in Spanish patients with diabetes mellitus and deafness. Eur J Hum Genet. 2002;10:421-426.

65. Abdelhak S, Kalatzis V, Heilig R, et al. Protein, nucleotide, a human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nat Genet. 1997;15:157-164.

66. Abdelhak S, Kalatzis V, Heilig R, et al. Protein, nucleotide, clustering of mutations responsible for branchio-oto-renal (BOR) syndrome in the eyes absent homologous region (eyaHR) of EYA1. Hum Mol Genet. 1997;6:2247-2255.

67. Kumar S, Kimberling WJ, Weston MD, et al. Identification of three novel mutations in human EYA1 protein associated with branchio-oto-renal syndrome. Hum Mutat. 1998;11:443-449.

68. Kumar S, Deffenbacher K, Cremers CW, et al. Branchio-oto-renal syndrome: identification of novel mutations, molecular characterization, mutation distribution, and prospects for genetic testing. Genet Test. 1998;1:243-251.

69. Usami S, Abe S, Shinkawa H, et al. EYA1 nonsense mutation in a Japanese branchio-oto-renal syndrome family. J Hum Genet. 1999;44:261-265.

70. Fraser FC, Sproule JR, Halal F. Frequency of the branchio-oto-renal (BOR) syndrome in children with profound hearing loss. Am J Med Genet. 1980;7:341-349.

71. Chen A, Francis M, Ni L, et al. Phenotypic manifestations of bran-chio-oto-renal syndrome. Am J Med Genet. 1995;58:365-370.

72. Carmi R, Binshtock M, Abeliovich D. The branchio-oto-renal (BOR) syndrome: report of bilateral renal agenesis in three sibs. Am J Med Genet. 1983;14:625-627.

73. Cremers CWRJ, Fikkers-Van Noord M. The earpits-deafness syndrome: clinical and genetic aspects. Int J Pediatr Otorhinolaryngol. 1980;2:309-322.

74. Greenberg CR, Trevenen CL, Evans JA. The BOR syndrome and renal agenesis. Prenatal Diagn. 1988;8:103-108.

75. Van Widdershoven J, Monnens L, Assmann K, et al. Renal disorders in the branchio-oto-renal syndrome. Helv Paediatr Acta. 1983;38: 513-522.

76. Chitayat D, Hodgkinson KA, Chen MF, et al. Branchio-oto-renal syndrome: further delineation of an underdiagnosed syndrome. Am J Med Genet. 1992;43:970-975.

77. Fitch N, Sorolovitz H. Severe renal dysgenesis produced by a dominant gene. Am J Dis Child. 1976;130:1356-1357.

78. Gu JZ, Wagner MJ, Haan EA, et al. Detection of a megabase deletion in a patient with branchio-oto-renal syndrome (BOR) and tricho-rhino-phalangeal syndrome (TRPS): implications for mapping and cloning of the BOR gene. Genomics. 1996;31:201-206.

79. Haan EA, Hull YJ, White S, et al. Tricho-rhino-phalangeal and bran-chio-oto syndromes in a family with an inherited rearrangement of chromosome 8q. Am J Med Genet. 1989;32:490-494.

80. Vincent C, Kalatzis V, Compain S, et al. A proposed new contiguous gene syndrome on 8q consists of branchio-oto-renal (BOR) syndrome, Duane syndrome, a dominant form of hydrocephalus and trapeze aplasia: implications for the mapping of the BOR gene. Hum Mol Genet. 1994;3:1859-1866.

81. Vervoort V, Smith RJH, O'Brien J, et al. Genomic rearrangements of EYA1 account for a large fraction of families with BOR syndrome. Eur J Hum Genet. 2002;10:757-766.

Was this article helpful?

0 0
Hearing Aids Inside Out

Hearing Aids Inside Out

Have you recently experienced hearing loss? Most probably you need hearing aids, but don't know much about them. To learn everything you need to know about hearing aids, read the eBook, Hearing Aids Inside Out. The book comprises 113 pages of excellent content utterly free of technical jargon, written in simple language, and in a flowing style that can easily be read and understood by all.

Get My Free Ebook


Post a comment